This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/DMRA/capital-change-brief"
Use Arkolith's capital_change_brief for DMRA. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | $234.3M | 9.0M | ▲38× Added · +8.8M sh | Q1 2026 | |
| 2 | Fairmount Funds Management LLC | $225.7M | 8.7M | ▲New +8.7M sh | Q1 2026 | |
| 3 | Avoro Capital Advisors LLC | $98.0M | 3.8M | ▲New +3.8M sh | Q1 2026 | |
| 4 | Venrock Adviser, LLC | $93.3M | 3.6M | ▲New +3.6M sh | Q1 2026 | |
| 5 | FCPM III SERVICES B.V. | $63.2M | 2.4M | ▲New +2.4M sh | Q1 2026 | |
| 6 | RA CAPITAL MANAGEMENT, L.P. | $62.1M | 2.4M | ▲New +2.4M sh | Q1 2026 | |
| 7 | JANUS HENDERSON GROUP PLC | $61.4M | 2.4M | ▲1k× Added · +2.4M sh | Q1 2026 | |
| 8 | VIKING GLOBAL INVESTORS LP | $59.9M | 2.3M | ▲New +2.3M sh | Q1 2026 | |
| 9 | Bellevue Group AG | $59.5M | 2.3M | ▲New +2.3M sh | Q1 2026 | |
| 10 | Remedium Capital Partners, LLC | $53.0M | 2.0M | ▲17× Added · +1.9M sh | Q1 2026 | |
| 11 | Commodore Capital LP | $50.2M | 1.9M | ▲New +1.9M sh | Q1 2026 | |
| 12 | Cormorant Asset Management, LP | $39.5M | 1.5M | ▲New +1.5M sh | Q1 2026 | |
| 13 | BALYASNY ASSET MANAGEMENT L.P. | $37.5M | 1.4M | ▲New +1.4M sh | Q1 2026 | |
| 14 | PERCEPTIVE ADVISORS LLC | $31.7M | 1.2M | ▲New +1.2M sh | Q1 2026 | |
| 15 | Point72 Asset Management, L.P. | $30.9M | 1.2M | ▲11× Added · +1.1M sh | Q1 2026 | |
| 16 | Siren, L.L.C. | $23.3M | 900K | ▲New +900K sh | Q1 2026 | |
| 17 | BRAIDWELL LP | $23.2M | 895K | ▲New +895K sh | Q1 2026 | |
| 18 | Vestal Point Capital, LP | $15.5M | 600K | ▲New +600K sh | Q1 2026 | |
| 19 | Blackstone Inc. | $13.0M | 504K | ▲New +504K sh | Q1 2026 | |
| 20 | MILLENNIUM MANAGEMENT LLC | $12.2M | 472K | ▲New +472K sh | Q1 2026 | |
| 21 | Affinity Asset Advisors, LLC | $11.7M | 450K | ▲New +450K sh | Q1 2026 | |
| 22 | Ikarian Capital, LLC | $8.7M | 336K | ▲+18% Added · +50K sh | Q1 2026 | |
| 23 | Qube Research & Technologies Ltd | $7.3M | 282K | ▲New +282K sh | Q1 2026 | |
| 24 | ADAR1 Capital Management, LLC | $7.2M | 279K | ▲New +279K sh | Q1 2026 | |
| 25 | Nantahala Capital Management, LLC | $7.2M | 278K | ▲New +278K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Jul 6, 2026 | Winslow Garrett | General Counsel | Sell (S) | 245 | $7K |
| Jul 3, 2026 | Winslow Garrett | General Counsel | Option exercise (M) | 680 | — |
| Jul 3, 2026 | Winslow Garrett | General Counsel | Option exercise (M) | 680 | $0 |
| Mar 30, 2026 | Jarrett Jennifer | See Remarks, Director | Grant (A) | 500K | $0 |
| Mar 30, 2026 | Jarrett Jennifer | See Remarks, Director | Grant (A) | 1.5M | $0 |
| Mar 23, 2026 | Bruno Julianne | Director | Grant (A) | 37K | $0 |
| Mar 23, 2026 | CAIN CHRISTOPHER W. | Director | Grant (A) | 37K | $0 |
| Mar 23, 2026 | Fairmount Healthcare Fund II L.P. | Director, 10% Owner | Grant (A) | 37K | $0 |
| Mar 23, 2026 | Landsittel Michael | Director | Grant (A) | 37K | $0 |
| Mar 23, 2026 | Turtle Cameron | Director | Grant (A) | 37K | $0 |
| Mar 23, 2026 | Winslow Garrett | General Counsel | Grant (A) | 250K | $0 |
| Company | Co-held by | Combined value |
|---|---|---|
| CENTESSA PHARMACEUTICALS-ADRCNTA | 15 funds | $863.1M |
| COGENT BIOSCIENCES INCCOGT | 14 funds | $396.0M |
| BOSTON SCIENTIFIC CORPBSX | 13 funds | $529.8M |
| OLEMA PHARMACEUTICALS INCOLMA | 13 funds | $181.8M |
| ASCENDIS PHARMA A/SASNDUSD | 12 funds | $4.0B |
| MEDLINE INC-CL AMDLN | 12 funds | $745.2M |
| XENON PHARMACEUTICALS INCXENE | 12 funds | $616.1M |
| ORUKA THERAPEUTICS INCORKA | 12 funds | $458.9M |
| SOLID BIOSCIENCES INCSLDB | 12 funds | $268.4M |
| TANGO THERAPEUTICS INCTNGX | 12 funds | $267.7M |
| UNIQURE NVQURE | 12 funds | $130.6M |
| AMAZON.COM INCAMZN | 11 funds | $2.2B |
Ranked by how many of DMRA's institutional holders also hold each name, a cross-fund conviction signal. Via the MCP server (ticker.co_held).
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for DMRA. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes. Every panel above is one call to the Arkolith API & MCP server.